Fermenta Biotech Limited (BOM:506414)
293.20
+2.60 (0.89%)
At close: May 27, 2026
Fermenta Biotech Revenue
In the fiscal year ending March 31, 2026, Fermenta Biotech had annual revenue of 5.48B INR with 16.69% growth. Fermenta Biotech had revenue of 1.27B in the quarter ending March 31, 2026, a decrease of -9.44%.
Revenue
5.48B
Revenue Growth
+16.69%
P/S Ratio
1.56
Revenue / Employee
9.04M
Employees
606
Market Cap
8.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.48B | 783.37M | 16.69% |
| Mar 31, 2025 | 4.69B | 1.34B | 39.87% |
| Mar 31, 2024 | 3.36B | -142.79M | -4.08% |
| Mar 31, 2023 | 3.50B | -485.75M | -12.19% |
| Mar 31, 2022 | 3.99B | 212.27M | 5.63% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TTK Healthcare | 8.30B |
| Anuh Pharma | 7.76B |
| Sudarshan Pharma Industries | 7.12B |
| Venus Remedies | 7.03B |
| Kopran | 6.81B |
| Wanbury | 6.58B |
| Fredun Pharmaceuticals | 5.91B |
| Syncom Formulations (India) | 5.21B |